HighTower Advisors LLC Increases Position in Humana Inc. $HUM

HighTower Advisors LLC grew its stake in Humana Inc. (NYSE:HUM) by 8.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,630 shares of the insurance provider’s stock after acquiring an additional 583 shares during the quarter. HighTower Advisors LLC’s holdings in Humana were worth $2,019,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Deutsche Bank AG increased its holdings in shares of Humana by 18.2% in the 4th quarter. Deutsche Bank AG now owns 631,371 shares of the insurance provider’s stock valued at $160,185,000 after acquiring an additional 97,071 shares during the period. Janney Montgomery Scott LLC acquired a new stake in shares of Humana in the 1st quarter worth $1,309,000. Fred Alger Management LLC acquired a new stake in shares of Humana in the 4th quarter worth $451,000. Clearline Capital LP acquired a new stake in shares of Humana in the 4th quarter worth $1,102,000. Finally, Envestnet Asset Management Inc. boosted its position in shares of Humana by 2.4% in the 1st quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider’s stock worth $33,256,000 after purchasing an additional 2,950 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on HUM shares. Piper Sandler lowered their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Robert W. Baird lowered their price objective on Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Oppenheimer raised their price objective on Humana from $300.00 to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, May 1st. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research report on Thursday, May 1st. Finally, Truist Financial lowered their price target on Humana from $280.00 to $260.00 and set a “hold” rating for the company in a research report on Wednesday, July 16th. Seven equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $283.29.

Humana Stock Performance

Shares of HUM opened at $300.0120 on Friday. The stock has a 50-day moving average of $248.58 and a two-hundred day moving average of $253.48. Humana Inc. has a one year low of $206.87 and a one year high of $382.72. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a market cap of $36.08 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.76 and a beta of 0.44.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana’s dividend payout ratio (DPR) is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.